Assessments of fatigue and disease activity in patients with systemic lupus erythematosus enrolled in the Phase 2 clinical trial with blisibimod.
Autor: | Petri, M. A.1, Martin, R. S.2 rmartin@anthera.com, Scheinberg, M. A.3, Furie, R. A.4 |
---|---|
Zdroj: | Lupus. Jan2017, Vol. 26 Issue 1, p27-37. 11p. 2 Charts, 4 Graphs. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |